Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer

The present study investigated the interaction between c-erbB2 overexpression and the response to first-line endocrine therapy in patients with advanced breast cancer. The primary tumours of 241 patients who were treated at first relapse with endocrine therapy were assessed for overexpression of c-e...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Stephen Houston, T.A. Plunkett, D M Barnes, Paul Smith, R.D. Rubens, David Miles
Format: Artigo
Język:angielski
Wydane: 1999
Dostęp online:https://doi.org/10.1038/sj.bjc.6690196
https://www.nature.com/articles/6690196.pdf
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!